Healthcare and Medical

How is Next Generation Sequencing (NGS) Technology Applied in Gynecological Cancer Diagnostics?

Aryan Kumar

How is Next Generation Sequencing (NGS) Technology Applied in Gynecological Cancer Diagnostics?

The field of next-generation gynecological cancer diagnostics is experiencing continuous growth due to various factors such as the rising incidence of diabetes, increasing prevalence of gynecological malignancies, obesity in women, lifestyle changes, and menopause problems.

Advancements in sequencing technologies have empowered researchers and clinicians to gain insights into underlying mutations associated with gynecological cancers, leading to the discovery of biomarkers that guide targeted therapeutic decisions.

These diagnostic tests also enable early detection of cancers and other diseases, as well as accurate prognosis, which contributes to the future growth of the next-generation gynecological cancer diagnostics sector.

Uterine, cervical, and ovarian cancers are the most common gynecological cancer types in females globally. These cancers result from acquired and inherited mutations, epigenetic factors, genomic aberrations, transcriptional aberrations, or a combination of these factors. A comprehensive understanding of genomics, molecular substructure, and gynecologic cancers is essential to develop effective biomarkers for detection, prevention, molecular profiling, and personalized treatment strategies.

Next-generation gynecological cancer diagnostics play an important role in controlling, preventing, and investigating cancerous diseases.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=next-generation-gynecological-cancer-diagnostics-market

Uses Case of Next-Generation Gynecological Cancer Diagnostics

Next-generation gynecological cancer diagnostics are used for the detection of various cancers, including ovarian, uterine, vulvar, cervical, and vaginal cancer.

Among these, the utilization of these diagnostics for uterine cancer is particularly high and continuously increasing. This is due to the rising global incidence of uterine cancer, driven by factors such as increased menopause issues after age 55, higher prevalence of high blood sugar levels and blood pressure, the aging female population, rising rates of obesity and overweight, and elevated estrogen levels.

Furthermore, the utilization of these diagnostics for cervical cancer is expected to increase in the future, considering the growing prevalence of cervical malignancies in women worldwide.

Application of Next-Generation Sequencing (NGS) Technology

Next-generation gynecological cancer diagnostics employ technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and DNA microarrays.

NGS technology is particularly prominent in this field, as it can identify actionable genetic alterations that can be targeted with therapy. NGS demonstrates a 33.4% chance of identifying gynecologic cancers and exhibits a high clinical action rate. The clinical utility of NGS has also been shown to improve survival in individuals who receive targeted treatment.

Additionally, NGS plays an important role in tumor analysis and has greatly facilitated the molecular profiling of solid tumors.

DNA microarrays technology is also increasingly utilized in this context. These microarrays provide a powerful and advanced approach to studying the molecular basis of relationships on a scale that conventional methods cannot achieve.

Furthermore, they enable the simultaneous assessment of the expression of thousands of genes, leading to the development of rationale approaches for therapy, as well as advancements in gynecological cancer diagnosis and prognosis. As a result, DNA microarrays find wide application in hospitals and diagnostic laboratories.

Hence, with the advancements of technology in healthcare, developing infrastructure of healthcare, implementing advanced and rapid diagnosis of diseases, and mounting investment by both domestic and foreign businesses across Asian countries, the demand for next-generation gynecological cancer diagnostics will continue to increase, and it will reach a value of USD 5,135 million by the end of this decade.

Aryan Kumar

Next-Generation Gynecological Cancer Diagnostics Market Dynamics, Competitive Analysis & Future Outlook

bisresearch reports 2022-03-28

• What are the major market drivers, restraints, and opportunities in the global next-generation gynecological cancer diagnostics market? • What was the market size of the leading segments and sub-segments of the global next-generation gynecological cancer diagnostics market in 2020? • What will be the growth rate of the next-generation gynecological cancer diagnostics market during the forecast period 2021-2031? • What is the market size of the next-generation gynecological cancer diagnostics market in different countries of the world? • What are the reimbursement scenarios and regulatory structures for the next-generation gynecological cancer diagnostics market in different regions?

Next-Generation Sequencing Technologies Guide Cancer Diagnosis and Treatment

Vivian Creative 2022-07-20

A recent study reveals representative data about how next-generation sequencing (NGS) tests are practically used by oncologists in the United States to evaluate cancer patients and how these technologies guide cancer treatment recommendations. These tumor markers can guide treatment decisions for a specific type of cancer and monitor cancer during and after treatment, which is known as precision oncology. Whole-exome sequencing (WES) is one of the major NGS technologies widely used in cancer sequencing. And the global next-generation cancer diagnostics market is expected to grow to $16. Generally speaking, the pivotal role of sequencing technologies in cancer research drives continuous advancements in the NGS market.

Next Generation Sequencing Market is Expected to Grow with High Probability Business Opportunity by 2030

Hemantkolhe 2021-10-30

The global Next Generation Sequencing Market report offers a comprehensive assessment of the market for the forecast years.

The report contains several segments and an analysis of the market trends and growth factors that are playing a vital role in the market.

This global industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2030.The leading companies in Global Next Generation Sequencing Market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile, and STD Reimbursement Scenario Analysis, and Top Study Testing Technologies products and services.The key market players for the global Next Generation Sequencing Market are listed below:Agilent Technologies, IncBGI Group F. Hoffmann-La Roche AG Illumina IncPrecigen Inc., (Intrexon Bioinformatics Germany GmbH)Pacific Biosciences of California, IncPerkinElmer, Inc.PierianDx Inc.Qiagen N.V.Thermo Fisher Scientific Inc.(A PDF | Sample Of The Report Is Available Immediately Upon Request) @ https://www.alliedmarketresearch.com/request-sample/2048 The Global Next Generation Sequencing Market Report is equipped with market data from 2021 to 2030.

It also evaluates the competitive scenario of the leading players.

The detailed sales channel is also covered in the study.Covid-19 Scenario:1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.Detailed COVID-19 Impact Analysis on Market: https://www.alliedmarketresearch.com/request-for-customization/2048?reqfor=covid Why Purchase this Report?A robust research methodology has been followed to collect data for the report.

Data, thus collected passes through multiple quality checks to ensure the best quality is served.The report gives a holistic view of the competitive scenario of the Next Generation Sequencing Market.The latest product launches along with technological changes and development are covered in the report.The data analysis in the report helps in understanding the anticipated Next Generation Sequencing Market dynamics from 2021 to 2030.Decision Databases has a vast repository of data, therefore, we can accommodate customized requirements also.The graphs, tables and pie charts, and info-graphics covered in the report will help in a better understanding of the report.The market drivers, restraints, upcoming opportunities, and anticipated restraints cited in the report will assist in making an informed decision.Interested in Procuring this Report?

Next Generation Sequencing (NGS) Market Overview with Size & Growth Share, Industry Dynamics, and Forecast

gogo 2022-05-09

It is a specialized and in-depth study of the industry with a special focus on the global Next Generation Sequencing (Ngs) Market trend analysis. According to the research report, “According to the research report published by Polaris Market Research, the Global Next Generation Sequencing Market Expected To Reach Us$ 25. The report highlights the key opportunities available in the market and the factors that are and will be driving the growth of the global Next Generation Sequencing (Ngs) Market industry. Country-wise volume analysis and region-wise market size analysis of the global Next Generation Sequencing (Ngs) Market. Benefits of This Market Report:You will get a comprehensive evaluation of all opportunities and risks in the global Next Generation Sequencing (Ngs) Market.

Next-Generation Sequencing (NGS) Services Market Expected to Witness a Significant Growth of USD 32,335.31 Million by 2029 | CAGR of 22.00% by Data Bridge Market Research

Bishal Gupta 2022-06-29

Data Bridge Market Research analyses that the next-generation sequencing (NGS) services market is expected to undergo a CAGR of 22. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. dbmr=global-ngs-services-market Next-Generation Sequencing (NGS) Services Market research study explores actionable market insights with which sustainable and money-spinning business strategies can be formed. com/reports/asia-pacific-digital-diabetes-management-market Some of the Major Highlights of Toc Covered: –IntroductionAssumptions and Research MethodologyExecutive SummaryMarket OverviewKey InsightsGlobal Next-Generation Sequencing (NGS) Services Market Analysis and Forecast, By ProductAsia Pacific Next-Generation Sequencing (NGS) Services Market Analysis and ForecastLatin America Next-Generation Sequencing (NGS) Services Market Analysis and ForecastMiddle East & Africa Next-Generation Sequencing (NGS) Services Market Analysis and ForecastCompetitive Landscape Get TOC Details:https://www. dbmr=global-ngs-services-market Key Players Next-Generation Sequencing (NGS) Services MarketThe major players covered in the Next-Generation Sequencing (NGS) Services Market report areMedtronic (Ireland),BD (U.

The Booming Next Generation Sequencing (NGS) Market (Industry Report: 2023-2033)

Tanzeel Obaid 2023-06-21

Next-generation sequencing (NGS) is a powerful technology that allows for the rapid and accurate sequencing of large amounts of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). The Road AheadNGS has been a transformative technology in genomics, enabling rapid and cost-effective sequencing of DNA and RNA. Advancements in base-calling algorithms, error correction techniques, and improvements in sequencing chemistry are expected to enhance the accuracy of sequencing data. The Next Generation Sequencing Market was valued at $6. The opportunity for growth of the global NGS market lies in the development of economical and portable technologies.

WHO TO FOLLOW

MORE FROM AUTHOR

Why Interactive Kiosks Are Installed in Public Places?

Aryan Kumar 2024-03-08

Hospitals are the Largest End- Users of Endoscopes Worldwide

Aryan Kumar 2023-12-21

Microarray Analysis Industry Analysis and Growth Forecast to 2030

Aryan Kumar 2023-11-30

Endoscopic Submucosal Dissection Industry Growth and Demand Forecast to 2030

Aryan Kumar 2023-09-04

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Delayed cancer screening and diagnosis due to pandemic related restrictions and re-prioritizations have led to a pent-up demand in Next–Gen Cancer Care Technologies: Ken Research

Ken Research 2023-01-19

The Oncology Devices market is moderately consolidated with major international brands dominating the market. The solutions (testing) market is moderately fragmented with presence of 6000+ NABL-accredited labs, around 70 dedicated cancer care hospitals. Growing Healthcare Sector Expenditure: The union budget FY’2022-2023 allocated ₹ 86,200 Cr to the Ministry of Health & Family Welfare, nearly 16. Entry of Global Manufacturers, Rising technology advancements are some of the factors that will contributed to the India Next-Gen Oncology market growth over the period of FY’2022-2027F. It is expected that India Oncology Devices and Solutions Market will grow at a CAGR of 23.

CD Genomics Perspective: The Application of RNA-Seq and DNA-Seq in Cancer Research

Kiko Garcia 2021-11-29

Clinicians can make better diagnostic and treatment decisions using the data obtained by next-generation sequencing (NGS) technologies. Today, commercially available microarray-based tests enable more accurate cancer profiling based on genetic biomarkers like HER2, ER, and PR. The gene expression patterns linked with the existence of diverse immunocyte populations can subsequently be inferred using analytical approaches to deconstruct genomics data. Many analyses, such as differential gene expression analysis, immunological gene signature analysis, gene pathway analysis, T/B-cell receptor inference, HLA inference, and viral transcript quantification, can be performed on the data after it has been sequenced. The order of the nucleotides or base pairs that make up a DNA molecule is determined through DNA sequencing.

Next Generation Sequencing Market Growth 2023, Industry Share, Emerging Trends, Demand, Business Challenges and Future Opportunities, Forecast Analysis 2033: SPER Market Research

sonali sharma 2023-10-11

According to SPER market research, ‘Next Generation Sequencing Market Size- By Product Type, By Type of Sequencing Technology, By Application, By End-User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Global Next Generation Sequencing Market is predicted to reach USD 129. Also, expanding genomics programmes across a number of countries to predict the expansion of the market for next-generation sequencing. The global market for next-generation sequencing is expected to increase significantly due to rising applications in clinical diagnosis. The development of diagnostics based on next-generation sequencing and encouraging government support are the market drivers for next-generation sequencing. By Type of Sequencing Technology: Based on the Type of Sequencing Technology, Global Next Generation Sequencing Market is segmented as; CHIP Sequencing, De Novo Sequencing, Methyl Sequencing, RNA Sequencing, Targeted Resequencing, Whole Exome Sequencing, Whole Genome Sequencing.

Global Next Generation Sequencing (NGS) Market Trends, Industry Report 2028

Bulletin 2021-05-13

New York, NY 13 May 2021: The global next generation sequencing market expected to reach US$ 25.85 billion by 2028 according to a new study by Polaris Market Research.

The report “Next Generation Sequencing (NGS) Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery/Personalized Medicine, Genetic Screening, Diagnostics/Infectious Diseases, Agricultural & Animal Research); By Technology; By Product; By End-Use; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Market players are focusing on developing automated sequencers equipped with high speed and accuracy.

This has also enabled increased adoption in emerging nations.

In terms of application, the market is segmented into drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others.

Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-sample Segment HighlightsInfectious diseases segment is estimated to hold a major share in the global next generation sequencing market, owing to increasing usage of NGS in infectious diseases.

Next Generation Sequencing Market Strengthen its Position in Healthcare Sector by Latest Innovations, Industry Challenges and Opportunities Market Size, Share and Foreseen to 2023

Bhagyashri Bhole 2020-02-03

Next Generation Sequencing Market Research Report: By Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing and Whole Exome Sequencing), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), Application (Oncology, Clinical Investigation, Reproductive Health, Human Leukocyte Antigen Typing or Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, Consumer Genomics), End User (Hospitals & Clinics, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Global Forecast till 2025Global Next Generation Sequencing Market Share is expected to exhibit significant growth over the forecast period.

The NGS Market Growth is projected to register a CAGR of 18.05% over the forecast period to reach USD 20,347.45 Million by 2025.There are various diseases that have their roots in genetics such as cancer, diabetes, Alzheimer’s, arthritis, heart disease etc.

To discover viable treatment to these diseases, researchers are looking to discern how genes work.

Next generation sequencing market has been gaining impetus due to the fact that next-generation sequencing is integral to field of genomics.

The NGS technologies are implemented for several applications, including whole genome sequencing, de novo assembly sequencing, resequencing, and transcriptome sequencing at the DNA or RNA level.

The successful application of next-generation sequencing can lead to predicting of genes, protein coding regions, and pathways.Illumina, Helicos Biosciences, Thermo Fisher Scientific, Roche, Pacific Bioscience, ABI Life Technologies, and Oxford Nanopore are some of the companies that are implementing different NGS technologies which in turn will augment global next generation sequencing market which is estimated to reach a massive market valuation by 2023.Next Generation Sequencing Market Competitive Landscape:Some of the key players in the global next-generation sequencing market Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., BGI, PerkinElmer, Agilent Technologies, QIAGEN N. V., Macrogen Inc., Oxford Nanopore Technologies, Ltd., and Eurofins Scientific.

Navigating the Future of Cancer Diagnostics

Pooja salve 2023-07-24

As we navigate the future of cancer diagnostics, exciting advancements and challenges await us on this transformative path. One of the most promising developments in cancer diagnostics is the advent of liquid biopsies. Artificial Intelligence (AI) is another groundbreaking technology shaping the future of Cancer Diagnostics. In conclusion, the future of Cancer Diagnostics is brimming with possibilities. By fostering innovation, addressing ethical concerns, and ensuring equal access, we can forge a future where cancer diagnostics contribute significantly to the global fight against cancer.

NGS Library Preparation Market- Global Opportunity Analysis and Industry Forecast (2022-2029)

shital12345 2022-11-22

’According to this latest publication from Meticulous Research®, the NGS library preparation market is expected to reach $3. com/download-sample-report/cp_id=5319Scope of the Report:NGS Library Preparation Market, by Product· Reagents & Consumableso Library Preparation Kitso DNA Library Preparation Kitso RNA Library Preparation Kitso Other Reagents & Consumables· Instruments & Workstations (Note: Other reagents & consumables include various extraction kits, amplification kits, consumables, and laboratory reagents)NGS Library Preparation Market, by Application· Disease Diagnosticso Cancer Diagnosticso Reproductive Health Diagnosticso Infectious Disease Diagnosticso Other Disease Diagnostic Applications· Drug Discovery· Other Applications (Note: Other disease diagnostic applications include applications in cardiovascular diseases, detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and foodborne illnesses. o Canada· Europeo Germanyo Franceo U. o Italyo Spaino Rest of Europe (RoE)· Asia-Pacifico Chinao Japano Indiao Rest of Asia-Pacific (RoAPAC)· Latin America· Middle East & AfricaSpeak with Our Analyst: https://www. com/speak-to-analyst/cp_id=5319NGS Library Preparation Market: Future OutlookThe NGS library preparation market is segmented based on product, application, sequencing type, end user, and geography.

Next Generation Sequencing Market Size, Revenue Share Analysis, Growth Forecast To 2027

Jason Miller 2022-02-15

The surge in focus on genomic research is expected to reinforce the growth of the next generation sequencing market. The next generation sequencing market size is expected to observe a stellar CAGR growth in the upcoming years. The accelerated rate of innovations in high throughput sequencing technology is projected to encourage the next generation sequencing market. Based on the type of technology, the next generation sequencing market has been segmented into whole exome sequencing, whole genome sequencing, methyl sequencing, RNA sequencing, CHIP sequencing, targeted resequencing, and de novo sequencing. com/reports/next-generation-sequencing-market-6354About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

Next Generation Sequencing Market Research Report CAGR Growth of 19.60 % and Predictive Business Strategy by 2026 | Potential Players Are Illumina, Inc., BGI, Eurofins Scientific, PerkinElmer Inc.

raftar r 2020-11-20

NGS means next-generation sequencing it is also known as massively parallel sequencing technology.

NGS allows researchers to research on various applications including speed, scalability, and ultra-high throughput and also study biological systems at a next level.

NGS allows researchers to rapidly sequence whole genomes.

Global next generation sequencing (NGS) market is registering a healthy CAGR of 19.60 % in the forecast period of 2019-2026.

This rise in the market can be attributed to the continuous advancement in NGS technology and upsurge in applications of NGS.

Get a Sample Copy of Global Next Generation Sequencing Market Report to Understand the Complete Insights @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-marketMarket Drivers and Restraints:Continuous technological advancement in NGS platform is driving the market growthReducing price of NGS installation is another factor helping in market growthProper reimbursement and improving regulatory scenario are flourishing the market growthUpsurge in applications of next generation sequencing drives the growth of the marketLess number of skilled personnel hinders the market growthRising concern about standardization of NGS based diagnostics hampers the market growthLegal and ethical restrictions will act as market restraintsThe major players covered in the Next Generation Sequencing MarketFew of the major market competitors currently working in the global next generation sequencing (NGS) market are Illumina, Inc., BGI, Eurofins Scientific, PerkinElmer Inc., Macrogen Inc., DNA Link, Inc., Genotypic Technology Pvt Ltd, WuXi AppTec, GENEWIZ, Takara Bio Inc., SciGenom Labs Pvt.

Global Next Generation Cancer Diagnostics Market

google 2022-03-09

The Global Next Generation Cancer Diagnostics Market accounted for US$ 5650. Analyst View:As the incidence of oncology problems develops, demand for next-generation cancer diagnostic tools is likely to rise. com/market_insight/Global-Next-Generation-Cancer-Diagnostics-Market-4748Key Market Insights from the report:The Global Next Generation Cancer Diagnostics Market accounted for US$ 5650. The Global Next Generation Cancer Diagnostics Market is segmented based on the technology, cancer type, application and region. html To know moreContact Us:SalesProphecy Market Insights 1 860 531 2701Email- sales@prophecymarketinsights.

Next Generation Sequencing Market Trends, Insights And Forecast To 2032

Bhuvan 2023-01-24

The Business Research Company’s Next Generation Sequencing Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The Next Generation Sequencing Global Market Report 2023 evaluates next generation sequencing market size, growth rate, drivers, trends, and major companies. id=3990&type=smpThe global next generation sequencing market size will grow from $9. The global next generation sequencing market size is expected to grow to $17. List Of Tables:Table 1: Global Historic Market Growth, 2017-2022, $ BillionTable 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ BillionTable 3: Global Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ BillionTable 4: Global Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ BillionTable 5: Global Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion….

Next Generation Sequencing (NGS) Industry Insights | Companies like Illumina are increasing their installation base by providing sequencing services in different emerging countries

susan hill 2019-09-12

The global next generation sequencing market is expected to reach USD 19.70 billion by 2025 registering a CAGR of 12.78%, according to a new report by Grand View Research, Inc.

Growing application of NGS methodologies due to rising number of strategic developments initiated by the market participants is one of the key drivers of the market.

These novel strategies mark the presence of intense competition between the key firms.

Companies are further increasing their installation base by providing sequencing services in different emerging countries.

For instance, in April 2018, Illumina entered into a partnership with Loxo Oncology for the development of Illumina TruSight Tumor 170 NGS test as a companion diagnostic for Loxo Oncology’s LOXO-292 and larotrectinib for tumor profiling.Similarly, in March 2018, PierianDx partnered with cancer genetics to offer NGS-based tests for oncology precision medicine.

NGS technologies experience significant growth due to rapid automation in the pre-sequencing protocols and advancements in clinical diagnosis and disease testing.

Next Generation Cancer Diagnostics Market Opportunity And Industry Expansion Strategies 2024

James Butler 2021-09-05

Global next generation cancer diagnostics market size was worth USD 4,964.05 million in 2016 which is anticipated to grow at a CAGR of more than 9.7% over the forecast period.

The introduction of new products by large bodies, merger, and acquisitions, and joint agreements such as the development of RNA-Seq Kit version by Agilent Technologies Inc. and Agendia Inc. are the factors accountable for the estimated CAGR.An escalation in the development of companion diagnostics in order to deliver advanced and personalized genomic medicine is also responsible for progress in the coming years.Furthermore, the technological advancements driving the innovation in point-of-care testing devices is anticipated to aid in commercialization of advanced products thereby supporting revenue generation.Download Sample Report @ https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market/request-sampleIncorporation of technological advancements such as melting curve examination for identification of mutations, qPCR tools for profiling of tumor in clinical test centers, and gene deletions are accountable for the largest share apprehended by multiplexing and qPCR segment.With the development of next-generation sequencing technology, the use of traditional methods such as protein and DNA microarrays is expected to decrease through the years.

Other factors such as data interpretation tools, growth of supportive library preparation procedures, and technological advancements are accountable for the lucrative adoption of next generation oncology tests among researchers.Cancer Type InsightsMajor categorization for the types of cancer includes cervical, breast, lung, colorectal, and other tumor forms.

The other types constitute leukemia, prostate, bladder, brain, skin, uterine, esophageal, Non-Hodgkin lymphoma, ovarian, liver, and thyroid.In 2015, as per World Health Organization lung cancer was accountable for approximately 1.7 million deaths.

Moreover, breast cancer incidence is also estimated to grow thereby escalating the demand for screening and diagnostic technologies.Application InsightsGrowth in the number of research schemes to develop novel products and services which enable primary detection of tumor-causing mutations is expected to affect the advancement in genetic analysis over the forecast period.

Biomarker tests offer greater sensitivity in screening and also demonstrate 90% accuracy levels in investigational studies which is attributive to induce progress in the coming years.Function InsightsRisk analysis, prognostic based diagnosis, tumor screening, therapeutic monitoring, & theranostics are the different functions of next generation oncology diagnostic tests.The prognostic diagnostics segment is anticipated to witness the fastest growth in the coming years as a consequence of higher adoption of prognosis which plays important role in designing oncology therapies and protocols for chemotherapy, radiation-based treatment, and gene therapy.Regional InsightsThe next generation cancer diagnostics market is dominated by North America with approximately 40% market share.

The Next Generation Sequencing Market is Estimated To Witness High Growth Owing To Advancing Personalized Medicine Trend

Anjali CMI 2023-11-08

The Next Generation Sequencing Market is estimated to be valued at US$ 588. arket key trends: One of the major trends contributing to the Next Generation Sequencing market growth is advancing personalized medicine. This widespread adoption of NGS in drug discovery, agrigenomics and other fields will drive the Next Generation Sequencing market over the forecast period. Key Takeaways The global Next Generation Sequencing Market Shareis expected to witness high growth, exhibiting CAGR of 18% over the forecast period, due to increasing R&D investments by pharmaceutical and biotechnology companies. Key players operating in the Next Generation Sequencing market are Thermo Fisher Scientific Inc.